6 reports

The company develops and markets advanced therapies that treat serious diseases such as chronic autoimmune diseases, including psoriasis, rheumatoid arthritis, and Crohn' s disease; human immunodeficiency virus; hepatitis C; thyroid disease; endometri

  • Lipid Modifying Drug
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • PIPELINE BY BIOCAD, H1 2018

It develops products in urology, gynecology, dermatology, oncology, hematology, autoimmune diseases and infectious diseases therapeutic areas.

  • Cardiovascular Disease
  • Lipid Modifying Drug
  • Therapy
  • United States
  • Product Initiative
  • 5. All the trials included are unique trials.

## ## A Phase IIIb, Multi-center, Double-blind, Placebo-controlled, Parallel Group, Study to Evaluate the Effect of Dalcetrapib ## mg on Cardiovascular (CV) Events in Adult Patients with Stable Coronary Heart Disease (CHD), CHD Risk Equivalents or at Elevated Risk for Cardi

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Pharmaceutical
  • World
  • DYSLIPIDEMIA - PIPELINE BY ILDONG PHARMACEUTICAL CO LTD, H1 2018

It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and neurological diseases.

  • Cholesterol
  • Chronic Disease
  • Lipid Modifying Drug
  • Pharmaceutical
  • Amarin Corporation plc

It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and neurological diseases.

  • Chronic Disease
  • Lipid Modifying Drug
  • United States
  • World
  • Product Initiative

The company focuses on major fields of oncology, autoimmune disease and ophthalmology with application to different indications.

  • Endocrine Disease
  • Lipid Modifying Drug
  • United States
  • Company
  • Product Initiative